Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats

International Immunopharmacology

Volumn 11, Issue 12, 2011, Pages 2181-2187

  Hubbard, J J ^a,c   Laurenzana, E M ^a,b   Williams, D K ^a   Gentry, W B ^a   Owens, S M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Addiction; Antibody medication; Monoclonal antibody; Phencyclidine; Pregnancy; Rat

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6B5; PHENCYCLIDINE; PHENCYCLIDINE MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERY CATHETER; ARTICLE; BINDING SITE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG HALF LIFE; DRUG SAFETY; FEMALE; FEMORAL ARTERY; FETUS DEATH; FETUS MORTALITY; GESTATION PERIOD; HEART RATE; HEMODYNAMICS; IMMUNITY; LITTER SIZE; LOCOMOTION; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; RAT; SECOND TRIMESTER PREGNANCY; TELEMETRY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD PRESSURE; FEMALE; FEMORAL ARTERY; FETAL DEATH; HEART RATE; MOTOR ACTIVITY; PHENCYCLIDINE; PREGNANCY; PREGNANCY OUTCOME; RATS;

EID: 81855221736     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.09.016     Document Type: Article

References (38)

1. W.B. Gentry, E.M. Laurenzana, D.K. Williams, J.R. West, R.J. Berg, and T. Terlea Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats Int Immunopharmacol 6 2006 968 977
2. K.M. Kantak Anti-cocaine vaccines: antibody protection against relapse Expert Opin Pharmacother 4 2003 213 218 (Pubitemid 36240460)
3. A. Killian, K. Bonese, R.M. Rothberg, B.H. Wainer, and C.R. Schuster Effects of passive immunization against morphine on heroin self-administration Pharmacol Biochem Behav 9 1978 347 352 (Pubitemid 9032938)
4. A.B. Norman, M.K. Norman, W.R. Buesing, M.R. Tabet, V.L. Tsibulsky, and W.J. Ball The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats J Pharmacol Exp Ther 328 2009 873 881
5. T.W. Smith, V.P. Butler Jr., E. Haber, H. Fozzard, F.I. Marcus, and W.F. Bremner Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases N Engl J Med 307 1982 1357 1362 (Pubitemid 13233011)
6. J.L. Valentine, M. Mayersohn, W.D. Wessinger, L.W. Arnold, and S.M. Owens Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats J Pharmacol Exp Ther 278 1996 709 716
7. WHO-UNODC Principles of drug dependence treatment 2008 World Health Organization New York 1 32
8. T. Kosten, and S.M. Owens Immunotherapy for the treatment of drug abuse Pharmacol Ther 108 2005 76 85 (Pubitemid 41377120)
9. J.W. Proksch, W.B. Gentry, and S.M. Owens The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum Drug Metab Dispos 28 2000 742 747 (Pubitemid 30470822)
10. E.M. Laurenzana, M.G. Gunnell, W.B. Gentry, and S.M. Owens Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody J Pharmacol Exp Ther 306 2003 1092 1098 (Pubitemid 37025318)
11. P.R. Pentel, M.B. Dufek, S.A. Roiko, M.G. Lesage, and D.E. Keyler Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats J Pharmacol Exp Ther 317 2006 660 666
12. J.W. Proksch, W.B. Gentry, and S.M. Owens Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats J Pharmacol Exp Ther 292 2000 831 837 (Pubitemid 30136572)
13. O.H. Brekke, and I. Sandlie Therapeutic antibodies for human diseases at the dawn of the twenty-first century Nat Rev Drug Discov 2 2003 52 62 (Pubitemid 37361624)
14. J. Bichler, G. Schondorfer, G. Pabst, and I. Andresen Pharmacokinetics of anti-D IgG in pregnant RhD-negative women BJOG 110 2003 39 45
15. J. Bichler, M.O. Spycher, H.P. Amstutz, I. Andresen, K. Gaede, and S. Miescher Pharmacokinetics and safety of recombinant anti-RhD in healthy RhD-negative male volunteers Transfus Med 14 2004 165 171 (Pubitemid 38623079)
16. K.M. Kantak, S.L. Collins, E.G. Lipman, J. Bond, K. Giovanoni, and B.S. Fox Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model Psychopharmacology (Berl) 148 2000 251 262 (Pubitemid 30136732)
17. D.E. Keyler, M.G. Lesage, M.B. Dufek, and P.R. Pentel Changes in maternal and fetal nicotine distribution after maternal administration of monoclonal nicotine-specific antibody to rats Int Immunopharmacol 6 2006 1665 1672 (Pubitemid 44344538)
18. D.E. Keyler, S.A. Roiko, E. Benlhabib, M.G. LeSage, J.V. St Peter, and S. Stewart Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships Drug Metab Dispos 33 2005 1056 1061 (Pubitemid 41002789)
19. D.E. Keyler, D. Shoeman, M.G. LeSage, A.D. Calvin, and P.R. Pentel Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats J Pharmacol Exp Ther 305 2003 587 592 (Pubitemid 36459174)
20. S.R. Zukin, Z. Sloboda, and D.C. Javitt Substance abuse: a comprehensive textbook 3rd ed. 1997 Williams & Wilkins Baltimore
21. D. Javitt Substance abuse: phencyclidine use disorders A. Tasman, Psychiatry 3rd ed. 2008 John Wiley & Sons Chichester, England; Hoboken, NJ 1090 1099
22. S.F. Ali, G. Ahmad, W. Slikker Jr., and S.C. Bondy Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain Neurotoxicology 10 1989 383 392 (Pubitemid 20084625)
23. J.C. Glantz, and J.R. Woods Jr. Cocaine, heroin, and phencyclidine: obstetric perspectives Clin Obstet Gynecol 36 1993 279 301 (Pubitemid 23133163)
24. R.A. Petrucha, K.R. Kaufman, and F.N. Pitts Phencyclidine in pregnancy: a case report J Reprod Med 27 1982 301 303
25. A.K. Jebelli, N. Doan, and G. Ellison Prenatal phencyclidine induces heightened neurodegeneration in rats in some brain regions, especially during 2nd trimester, but possible anti-apoptotic effects in others Pharmacol Toxicol 90 2002 20 25 (Pubitemid 34165256)
26. B.L. Tabor, T. Smith-Wallace, and M.L. Yonekura Perinatal outcome associated with PCP versus cocaine use Am J Drug Alcohol Abuse 16 1990 337 348
27. S. Patel Cardiovascular effects of intravenous anesthetics Int Anesthesiol Clin 40 2002 15 33 (Pubitemid 34075968)
28. M.M. McCarron, B.W. Schulze, G.A. Thompson, M.C. Conder, and W.A. Goetz Acute phencyclidine intoxication: clinical patterns, complications, and treatment Ann Emerg Med 10 1981 290 297 (Pubitemid 12103065)
29. G. Pitas, E.M. Laurenzana, D.K. Williams, S.M. Owens, and W.B. Gentry Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted Drug Metab Dispos 34 2006 906 912 (Pubitemid 43763745)
30. J.J. Hubbard, E.M. Laurenzana, D.K. Williams, W.B. Gentry, and S.M. Owens The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats J Pharmacol Exp Ther 336 2011 414 422
31. J.S. Hardin, W.D. Wessinger, J.W. Proksch, and S.M. Owens Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs J Pharmacol Exp Ther 285 1998 1113 1122 (Pubitemid 28277910)
32. S. Hayakawa, T. Fujikawa, H. Fukuoka, F. Chisima, M. Karasaki-Suzuki, and E. Ohkoshi Murine fetal resorption and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation J Reprod Immunol 47 2000 121 138 (Pubitemid 30621431)
33. E.J. Gralla Oxonic acid and fetal development: II. Teratogenicity in rats Toxicology 6 1976 299 307
34. J.S. Hardin, W.D. Wessinger, G.R. Wenger, J.W. Proksch, E.M. Laurenzana, and S.M. Owens A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats J Pharmacol Exp Ther 302 2002 119 126 (Pubitemid 34680429)
35. F. Faul, E. Erdfelder, A.G. Lang, and A. Buchner G ∠- Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences Behav Res Methods 39 2007 175 191
36. W.D. Wessinger, and S.M. Owens Phencyclidine dependence: the relationship of dose and serum concentrations to operant behavioral effects J Pharmacol Exp Ther 258 1991 207 215
37. C. Ikonomidou, F. Bosch, M. Miksa, P. Bittigau, J. Vockler, and K. Dikranian Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain Science 283 1999 70 74 (Pubitemid 29044848)
38. P.H. Su, Y.Z. Chang, and J.Y. Chen Infant with in utero ketamine exposure: quantitative measurement of residual dosage in hair Pediatr Neonatol 51 2010 279 284